Allspring Global Investments’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,522
| Closed | -$188K | – | 1787 |
|
|
2024
Q3 | $188K | Sell |
6,522
-65,946
| -91% | -$1.9M | ﹤0.01% | 1684 |
|
|
2024
Q2 | $2.78M | Sell |
72,468
-42,985
| -37% | -$1.65M | ﹤0.01% | 1072 |
|
|
2024
Q1 | $6.79M | Buy |
115,453
+56,178
| +95% | +$3.3M | 0.01% | 876 |
|
|
2023
Q4 | $3.55M | Sell |
59,275
-16,243
| -22% | -$972K | 0.01% | 1036 |
|
|
2023
Q3 | $2.87M | Sell |
75,518
-53,137
| -41% | -$2.02M | 0.01% | 1100 |
|
|
2023
Q2 | $11.7M | Sell |
128,655
-2,256
| -2% | -$206K | 0.02% | 744 |
|
|
2023
Q1 | $8.63M | Buy |
130,911
+4,118
| +3% | +$272K | 0.01% | 829 |
|
|
2022
Q4 | $6.56M | Buy |
126,793
+2,122
| +2% | +$110K | 0.01% | 907 |
|
|
2022
Q3 | $8.52M | Buy |
124,671
+119,363
| +2,249% | +$8.15M | 0.02% | 820 |
|
|
2022
Q2 | $240K | Sell |
5,308
-23,761
| -82% | -$1.07M | ﹤0.01% | 1765 |
|
|
2022
Q1 | $1.48M | Buy |
29,069
+2,301
| +9% | +$117K | ﹤0.01% | 1669 |
|
|
2021
Q4 | $1.27M | Buy |
+26,768
| New | +$1.27M | ﹤0.01% | 1796 |
|